Intensive Virtual Treatment with Remote Abstinence Monitoring for Alcohol Use Disorder
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202111WI1
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$393,984.06Funder
Canadian Institutes of Health Research (CIHR)Research Location
CanadaLead Research Institution
Centre for Addiction and Mental Health (Toronto)Research Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
Digital HealthStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
OtherOccupations of Interest
Unspecified
Abstract
The COVID-19 pandemic has had major impacts on both alcohol use and access to alcoholism treatment. For example, roughly a quarter of Canadians report increased alcohol consumption during the pandemic and there has been an increase in alcohol-related deaths among younger Canadians. At the same time, there has been a reduction in access to residential treatment (commonly known as rehabilitation or "rehab"), with evidence suggesting that the pandemic has led to greater delays in accessing residential treatment and poorer treatment retention. The transition to virtual care that has occurred during the pandemic offers the opportunity for high quality intensive care without the need for admission to a residential facility. The goal of the proposed pilot project is to assess the feasibility of a virtual intensive outpatient program for alcohol use disorder that aims to replicate the structure and abstinence monitoring of a residential treatment program. This virtual 4-week program at its core will consist of a 12-session manualized group cognitive behavioural therapy (delivered as 3 sessions per week) that has been demonstrated to reduce alcohol use. Participants will meet at least once per week with an addiction physician to ensure adequate medical management. Participants will be given Soberlink breathalyzers, which utilize facial recognition technology and internet connectivity to remotely monitor alcohol use. Individuals who are struggling to maintain abstinence will receive more intensive individual care (including more frequent physician and/or individual therapy appointments) during the program. Building an intensive virtual care program with remote abstinence monitoring offers the opportunity to address treatment barriers that have occured due to the pandemic by allowing high quality alcoholism care to be delivered at home. Furthermore, this program will reduce the need for brick-and-mortar facilities with 24/7 staffing requirements.